---
$id: https://graph.org.ai/products/commodity/51384629
$type: Product
source: UNSPSC
code: "51384629"
title: "Oxyphenbutazone anhydrous"
class: "51384600"
classTitle: "Nonsteroidal anti inflammatory pyrazoles"
family: "51380000"
familyTitle: "Nonsteroidal anti inflammatory drugs NSAIDs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Oxyphenbutazone anhydrous

**UNSPSC Code**: 51384629
**Class**: [Nonsteroidal anti inflammatory pyrazoles](Nonsteroidal anti inflammatory pyrazoles.mdx)
**Family**: [Nonsteroidal anti inflammatory drugs NSAIDs](../Nonsteroidal anti inflammatory drugs NSAIDs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a nonsteroidal antiinflammatory drug with the molecular formula C19H20N2O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier A7D84513GV, chemically known as (+/-)-oxyphenbutazone anhydrous, but more generally known as oxyphenbutazone anhydrous, which bears US NIH Compound Identifier 4641. European Medicines Agency schedules oxyphenbutazone anhydrous or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09572MIG. Most nations, for tariff purposes, schedule oxyphenbutazone anhydrous under HS 29331990. Oxyphenbutazone anhydrous bears US NLM identifiers UMLS ID C2698680 and NCI Concept Code C74597. SMILES: CCCCC1C(=O)N(N(C1=O)C2CCC(CC2)O)C3CCCCC3.

